✅ New API: 6000+ US Stock Options End-of-Day Data with 40+ fields. Learn more

Anebulo Pharmaceuticals Inc (ANEB NASDAQ) stock market data APIs

$2.4802 -0.03(-1.2%)
as of September 15, 2025
Try our APIs with free plan!

Anebulo Pharmaceuticals Inc Financial Data Overview

Price chart is built with Anychart
OpenFigi: BBG00ZWY**** The data is available with plans that include the Fundamentals API. Check our pricing page for details. CIK: 000181**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.

Prev. Close 2.4802
Open 2.4464
High 2.5482
Low 2.4802
52 wk Range 0.8001-3.42
Market Cap 101 M
Shares Outstanding 41 085 K
EPS 0
Beta -0.892

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Anebulo Pharmaceuticals Inc (top by weight)

Ticker
100-day Price Change
Weight
IWC.US iShares Micro-Cap ETF
21.66 (17.31%)
0.01
VTI.US Vanguard Total Stock Market Index Fund ETF Shares
31.66 (10.76%)
0.00
VXF.US Vanguard Extended Market Index Fund ETF Shares
21.33 (11.34%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Anebulo Pharmaceuticals Inc data using free add-ons & libraries


Get Anebulo Pharmaceuticals Inc Fundamental Data

Anebulo Pharmaceuticals Inc Fundamental data includes:

  • Net Revenue:
  • EBITDA:
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Anebulo Pharmaceuticals Inc Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-09-17
  • EPS/Forecast: -0.05
GET THE PACKAGE

Get Anebulo Pharmaceuticals Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Anebulo Pharmaceuticals Inc News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat